GSK Gross Margin Analysis

Gross margin is the percentage of revenue left after covering direct production costs, so GSK’s 73.1% means it retains that much from every dollar of sales.

This is well above the sector median of 46.4%, placing GSK in the 87th percentile among peers. The trend direction is not available: the year-over-year change is N/A, the quarter-over-quarter change is N/A, and only the current value of 73.1% has been reported. A high margin level is a positive signal for profitability, but the absence of trend data means you cannot tell whether this edge is growing or fading, creating uncertainty. That uncertainty tempers the opportunity despite the strong current level. On balance, the high margin supports the stock's fundamentals, but the missing trend aligns with the overall NEUTRAL verdict rather than pushing it toward a stronger rating.

Frequently Asked Questions